Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017
- PMID: 30361279
- PMCID: PMC6483895
- DOI: 10.1136/bjophthalmol-2018-312915
Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017
Abstract
Background/aims: Enucleation for retinoblastoma is performed less often in the past decade due to increasingly widespread alternative therapies, but enucleation remains an important option. There is a paucity of reports on the current incidence of metastases and metastatic deaths in unilateral retinoblastoma from US centres.
Methods:
Retrospective chart review at five tertiary retinoblastoma centres in the USA for unilateral retinoblastoma patients treated with primary enucleation, 2007-2017, with
Results: Among 228 patients (228 eyes), there were nine metastases (3.9%) and four deaths (1.7%). The Kaplan-Meier estimate at 5 years for metastasis-free survival was 96% (95% CI, 94% to 99 %), and for overall survival was 98% (95% CI 96% to 100%). All metastases were evident within 12 months. Histopathology revealed higher risk pathology (postlaminar optic nerve and/or massive choroidal invasion) in 62 of 228 eyes (27%). Of these higher risk eyes, 39 received adjuvant chemotherapy. There were four subsequent metastases in this higher risk pathology with adjuvant chemotherapy group, with three deaths. Of the nine overall with metastases, seven (78%) showed higher risk pathology. All metastatic patients were classified as Reese-Ellsworth V and International Classification of Retinoblastoma Groups D or E. Initial metastases presented as orbital invasion in seven of nine cases.
Conclusions: Primary enucleation for unilateral retinoblastoma results in a low rate of metastatic death, but is still associated with a 3.9% chance of metastases within a year of enucleation. Most but not all patients who developed metastases had higher risk histopathological findings.
Keywords: child health (paediatrics); epidemiology; neoplasia; retina.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: No authors have any interests relevant to this study to disclose. Interests outside of the submitted work: JEL, JHF, CLS, MDY, JLB, KK, AKM, PRS and DHA have nothing to disclose. IJD reports other from Apexigen, personal fees from Bayer, grants and personal fees from Bristol-Myers Squibb, personal fees from Celgene, personal fees from Eisai, personal fees from Ipsen, personal fees from Pfizer, grants from Genentech, outside the submitted work. AHS reports personal fees from Castle Biosciences, Inc, outside the submitted work. ABD reports grants from Research to Prevent Blindness, grants from Knights Templar Eye Foundation, grants from Alcon Research Institute, grants from Spectrum Pharmaceuticals, outside the submitted work.
Figures
Similar articles
-
Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.JAMA Ophthalmol. 2015 Sep;133(9):1062-6. doi: 10.1001/jamaophthalmol.2015.2243. JAMA Ophthalmol. 2015. PMID: 26181236 Free PMC article.
-
Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.Br J Ophthalmol. 2015 Oct;99(10):1366-71. doi: 10.1136/bjophthalmol-2014-306364. Epub 2015 Apr 14. Br J Ophthalmol. 2015. PMID: 25873648 Free PMC article.
-
Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.J Clin Oncol. 2013 Apr 10;31(11):1458-63. doi: 10.1200/JCO.2012.42.3962. Epub 2013 Mar 4. J Clin Oncol. 2013. PMID: 23460706 Clinical Trial.
-
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.Curr Opin Ophthalmol. 2010 May;21(3):203-12. doi: 10.1097/ICU.0b013e328338676a. Curr Opin Ophthalmol. 2010. PMID: 20224400 Review.
-
Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician.J Pediatr Ophthalmol Strabismus. 2004 May-Jun;41(3):143-9; quiz 172-3. doi: 10.3928/0191-3913-20040501-06. J Pediatr Ophthalmol Strabismus. 2004. PMID: 15206599 Review.
Cited by
-
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.Ophthalmology. 2020 Nov;127(11):1549-1557. doi: 10.1016/j.ophtha.2020.05.024. Epub 2020 May 15. Ophthalmology. 2020. PMID: 32422154 Free PMC article. Review.
-
Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework.Cancer Gene Ther. 2024 Mar;31(3):439-453. doi: 10.1038/s41417-023-00714-y. Epub 2023 Dec 25. Cancer Gene Ther. 2024. PMID: 38146007
-
Optic nerve thickening on high-spatial-resolution MRI predicts early-stage postlaminar optic nerve invasion in retinoblastoma.Eur Radiol. 2024 Jul;34(7):4638-4648. doi: 10.1007/s00330-023-10471-z. Epub 2023 Dec 13. Eur Radiol. 2024. PMID: 38087063
-
Comprehensive Analysis of the Immune Cell Infiltration Landscape and Immune-Related Methylation in Retinoblastoma.Front Genet. 2022 May 18;13:864473. doi: 10.3389/fgene.2022.864473. eCollection 2022. Front Genet. 2022. PMID: 35664300 Free PMC article.
-
The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma.J Cancer Res Clin Oncol. 2023 Mar;149(3):1313-1318. doi: 10.1007/s00432-022-04466-4. Epub 2022 Nov 10. J Cancer Res Clin Oncol. 2023. PMID: 36357738 Free PMC article.
References
-
- Albert DM. Historic Review of Retinoblastoma. Ophthalmology. 1987;94,(6):654–662. - PubMed
-
- Dunphy EB. The Story of Retinoblastoma. Am.J. Ophthalmol 1964;58(4):539–552. - PubMed
-
- Hirschberg J Der Markschwamm der Netzhaut; eine monographic. Hirschwald, Berlin; 1869.
-
- Wintersteiner H Das Neuroëpithelioma Retinae Eine anatomische and klinische Studie, Franz Deuticke, Vienna; 1897.
-
- Leber T Beiträge zur Kenntnis der Struktur des Netzhautglioms. Albrecht von Graefes Arch Ophthalmol, 1911;78:381–411
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous